Effects of Ro 40-5967, a novel calcium antagonist, on myocardial function during ischemia induced by lowering coronary perfusion pressure in dogs: comparison with verapamil.

Journal of cardiovascular pharmacology

Volumn 14, Issue 5, 1989, Pages 713-721

  Clozel, J P ^a   Banken, L ^a   Osterrieder, W ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; MIBEFRADIL; TETRALIN DERIVATIVE; VERAPAMIL;

ANIMAL; ARTICLE; BLOOD PRESSURE; COMPARATIVE STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DOG; DRUG EFFECT; HEART; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY;

ANIMALS; BENZIMIDAZOLES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CORONARY CIRCULATION; CORONARY DISEASE; DOGS; HEART; INJECTIONS, INTRAVENOUS; MIBEFRADIL; TETRAHYDRONAPHTHALENES; VERAPAMIL;

EID: 0024762508     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-198911000-00007     Document Type: Article

References (0)